OPHLF (Ono Pharmaceutical Co) Other Current Liabilities: $198 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OPHLF Ono Pharmaceutical Co Ltd OPHLF
74 GF Score
Price $15.56
GF Value $12.88
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ono Pharmaceutical Co Other Current Liabilities?

Ono Pharmaceutical Co OPHLF +0.01% 74 Other Current Liabilities is $198 Mil as of Mar. 2026. GuruFocus rates OPHLF with a GF Score™ of 74/100 and a GF Value™ of $12.88 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Ono Pharmaceutical Co's other current liabilities for the quarter that ended in Mar. 2026 was $198 Mil.

Ono Pharmaceutical Co's quarterly other current liabilities increased from Sep. 2025 ($154 Mil) to Dec. 2025 ($174 Mil) and increased from Dec. 2025 ($174 Mil) to Mar. 2026 ($198 Mil).

Ono Pharmaceutical Co's annual other current liabilities increased from Mar. 2024 ($124 Mil) to Mar. 2025 ($146 Mil) and increased from Mar. 2025 ($146 Mil) to Mar. 2026 ($198 Mil).

Ono Pharmaceutical Co Other Current Liabilities Related Terms

Ono Pharmaceutical Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Ono Pharmaceutical Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ono Pharmaceutical Co Other Current Liabilities Chart

Ono Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 104.66 142.67 123.68 145.79 198.19

Ono Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 145.79 173.30 154.42 174.38 198.19
OPHLF
74GF Score
Ono Pharmaceutical Co Ltd OPHLF
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ono Pharmaceutical Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $198 Mil mean?
Ono Pharmaceutical Co (OPHLF) has a Other Current Liabilities of $198 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ono Pharmaceutical Co.
Is Ono Pharmaceutical Co's Other Current Liabilities too high?
Ono Pharmaceutical Co's current Other Current Liabilities is $198 Mil. Overall, Ono Pharmaceutical Co has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ono Pharmaceutical Co's Other Current Liabilities compare to LLY and JNJ?
Ono Pharmaceutical Co's Other Current Liabilities of $198 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ono Pharmaceutical Co. Ono Pharmaceutical Co's current Other Current Liabilities is $198 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ono Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Ono Pharmaceutical Co (OPHLF) is currently considered Modestly Overvalued. The stock's GF Value™ is $12.88, compared to a current price of $15.56 — trading 20.8% above its estimated fair value. The current Other Current Liabilities is $198 Mil. Ono Pharmaceutical Co's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Ono Pharmaceutical Co (OPHLF), the current Other Current Liabilities is $198 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ono Pharmaceutical Co (OPHLF) Overvalued in 2026?

Based on GuruFocus' analysis, Ono Pharmaceutical Co stock appears to be overvalued. The current stock price of $15.56 is trading 20.8% above its estimated GF Value™ of $12.88. GuruFocus considers Ono Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for OPHLF:

  • Other Current Liabilities: $198 Mil
  • GF Value™: $12.88 vs. price of $15.56 (20.8% above fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the OPHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ono Pharmaceutical Co Business Description

Address 1-8-2 Kyutarocho, Chuo-ku, Osaka, JPN, 541-8564
Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in areas of unmet medical needs. The vast majority of the company's revenue is derived from its circulatory and respiratory drugs, followed by its metabolic drugs and vitamins. The company also reports revenue derived from royalties. The bulk of the company's sales is generated in Japan, followed by the rest of Asia and Europe.
74GF Score

Get the complete analysis for OPHLF

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.56
Price
$12.88
GF Value